Denali Therapeutics shares owned by Knights of Columbus Asset Advisors
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Knights of Columbus Asset Advisors
from 13F filings
Historical chart of Knights of Columbus Asset Advisors investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Knights of Columbus Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Knights of Columbus Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 39k | 29.13 |
| 2024-06-30 | $1.3M | 58k | 23.22 |
| 2024-03-31 | $809k | 39k | 20.52 |
| 2023-12-31 | $1.7M | 77k | 21.46 |
| 2023-09-30 | $787k | 38k | 20.63 |
| 2023-06-30 | $1.1M | 37k | 29.51 |
More positions owned by Knights of Columbus Asset Advisors
View all positions for Knights of Columbus Asset Advisors